120 related articles for article (PubMed ID: 20850538)
1. Overview of expression of hepatitis B surface antigen in transgenic plants.
Guan ZJ; Guo B; Huo YL; Guan ZP; Wei YH
Vaccine; 2010 Oct; 28(46):7351-62. PubMed ID: 20850538
[TBL] [Abstract][Full Text] [Related]
2. Production of hepatitis B surface antigen in recombinant plant systems: an update.
Kumar GB; Ganapathi TR; Bapat VA
Biotechnol Prog; 2007; 23(3):532-9. PubMed ID: 17348684
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form.
Smith ML; Mason HS; Shuler ML
Biotechnol Bioeng; 2002 Dec; 80(7):812-22. PubMed ID: 12402327
[TBL] [Abstract][Full Text] [Related]
4. Plant-based vaccines against human hepatitis B virus.
Shchelkunov SN; Shchelkunova GA
Expert Rev Vaccines; 2010 Aug; 9(8):947-55. PubMed ID: 20673016
[TBL] [Abstract][Full Text] [Related]
5. Production of hepatitis B surface antigen in transgenic plants for oral immunization.
Richter LJ; Thanavala Y; Arntzen CJ; Mason HS
Nat Biotechnol; 2000 Nov; 18(11):1167-71. PubMed ID: 11062435
[TBL] [Abstract][Full Text] [Related]
6. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
[TBL] [Abstract][Full Text] [Related]
7. Expression of human hepatitis B virus surface antigen gene in transgenic tobacco.
Liu YL; Wang JF; Qiu BS; Zhao SZ; Tian B
Sci China B; 1994 Jan; 37(1):37-41. PubMed ID: 8068185
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of transgenic tobacco plants carrying the gene for the surface antigen of the hepatitis B virus].
Rukavtsova EB; Zolova OE; Bur'ianova NIa; Borisova VN; Bykov VA; Bur'ianov IaI
Genetika; 2003 Jan; 39(1):51-6. PubMed ID: 12624933
[TBL] [Abstract][Full Text] [Related]
9. Study of the immunogenicity of hepatitis B surface antigen synthesized in transgenic potato plants with increased biosafety.
Rukavtsova EB; Rudenko NV; Puchko EN; Zakharchenko NS; Buryanov YI
J Biotechnol; 2015 Jun; 203():84-8. PubMed ID: 25840367
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of low doses of plant-based HBsAg induced antigen-specific IgAs and IgGs in mice, without increasing levels of regulatory T cells.
Kostrzak A; Cervantes Gonzalez M; Guetard D; Nagaraju DB; Wain-Hobson S; Tepfer D; Pniewski T; Sala M
Vaccine; 2009 Jul; 27(35):4798-807. PubMed ID: 19539581
[TBL] [Abstract][Full Text] [Related]
11. [Old and new prescriptions for infectious diseases and the newest recipes for biomedical products in plants].
Koprowski H
Arch Immunol Ther Exp (Warsz); 2002; 50(6):365-9. PubMed ID: 12549429
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice.
Shimizu Y; Guidotti LG; Fowler P; Chisari FV
J Immunol; 1998 Nov; 161(9):4520-9. PubMed ID: 9794377
[TBL] [Abstract][Full Text] [Related]
13. Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice.
Youm JW; Won YS; Jeon JH; Ryu CJ; Choi YK; Kim HC; Kim BD; Joung H; Kim HS
Vaccine; 2007 Jan; 25(3):577-84. PubMed ID: 16945456
[TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of an anti-(hepatitis B surface antigen) glycosylated mouse antibody in transgenic tobacco (Nicotiana tabacum) plants and its use in the immunopurification of its target antigen.
Ramírez N; Rodríguez M; Ayala M; Cremata J; Pérez M; Martínez A; Linares M; Hevia Y; Páez R; Valdés R; Gavilondo JV; Selman-Housein G
Biotechnol Appl Biochem; 2003 Dec; 38(Pt 3):223-30. PubMed ID: 12797866
[TBL] [Abstract][Full Text] [Related]
15. Expression of hepatitis B surface antigen in tobacco cell suspension cultures.
Sunil Kumar GB; Ganapathi TR; Revathi CJ; Prasad KS; Bapat VA
Protein Expr Purif; 2003 Nov; 32(1):10-7. PubMed ID: 14680934
[TBL] [Abstract][Full Text] [Related]
16. Process options in hepatitis B surface antigen extraction from transgenic potato.
Dogan B; Mason HS; Richter L; Hunter JB; Shuler ML
Biotechnol Prog; 2000; 16(3):435-41. PubMed ID: 10835246
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of a hepatitis B DNA vaccine administered to chronic HBV carriers.
Mancini-Bourgine M; Fontaine H; Bréchot C; Pol S; Michel ML
Vaccine; 2006 May; 24(21):4482-9. PubMed ID: 16310901
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
[TBL] [Abstract][Full Text] [Related]
19. [Construction of recombinant adeno-associated virus carrying hepatitis B surface antigen gene and preliminary study of the gene expression and function].
Hu GF; Wu XB; Yu SY; Dong XY; Chen Q; Hou YD
Di Yi Jun Yi Da Xue Xue Bao; 2003 Jun; 23(6):553-6. PubMed ID: 12810373
[TBL] [Abstract][Full Text] [Related]
20. Long-term benefit of hepatitis B vaccination among children in Thailand with transient hepatitis B virus infection who were born to hepatitis B surface antigen-positive mothers.
Poovorawan Y; Chongsrisawat V; Theamboonlers A; Srinivasa K; Hutagalung Y; Bock HL; Hoet B
J Infect Dis; 2009 Jul; 200(1):33-8. PubMed ID: 19473096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
